FibroGen Statistics Share Statistics FibroGen has 4.04M
shares outstanding. The number of shares has increased by -0.4%
in one year.
Shares Outstanding 4.04M Shares Change (YoY) -0.4% Shares Change (QoQ) -0.91% Owned by Institutions (%) 32.63% Shares Floating 3.63M Failed to Deliver (FTD) Shares 328 FTD / Avg. Volume 0.65%
Short Selling Information The latest short interest is 115.03K, so 2.84% of the outstanding
shares have been sold short.
Short Interest 115.03K Short % of Shares Out 2.84% Short % of Float 2.9% Short Ratio (days to cover) 2.37
Valuation Ratios The PE ratio is -27.84 and the forward
PE ratio is -0.81.
FibroGen's PEG ratio is
0.33.
PE Ratio -27.84 Forward PE -0.81 PS Ratio 44.72 Forward PS 4.9 PB Ratio -5.87 P/FCF Ratio -9.58 PEG Ratio 0.33
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for FibroGen.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.47,
with a Debt / Equity ratio of -0.32.
Current Ratio 1.47 Quick Ratio 1.45 Debt / Equity -0.32 Debt / EBITDA -0.51 Debt / FCF -0.53 Interest Coverage -18.24
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $131.65K Profits Per Employee $-211.46K Employee Count 225 Asset Turnover 0.14 Inventory Turnover 4.93
Taxes Income Tax -269K Effective Tax Rate 0.18%
Stock Price Statistics The stock price has increased by 21.16% in the
last 52 weeks. The beta is 0.77, so FibroGen's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change 21.16% 50-Day Moving Average 9.96 200-Day Moving Average 9.58 Relative Strength Index (RSI) 60.46 Average Volume (20 Days) 50,746
Income Statement In the last 12 months, FibroGen had revenue of 29.62M
and earned -47.58M
in profits. Earnings per share was -0.48.
Revenue 29.62M Gross Profit 14.06M Operating Income -150.42M Net Income -47.58M EBITDA -142.43M EBIT -145.12M Earnings Per Share (EPS) -0.48
Full Income Statement Balance Sheet The company has 50.48M in cash and 73.09M in
debt, giving a net cash position of -22.61M.
Cash & Cash Equivalents 50.48M Total Debt 73.09M Net Cash -22.61M Retained Earnings -1.89B Total Assets 178.06M Working Capital 6.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -138M
and capital expenditures -266K, giving a free cash flow of -138.26M.
Operating Cash Flow -138M Capital Expenditures -266K Free Cash Flow -138.26M FCF Per Share -1.38
Full Cash Flow Statement Margins Gross margin is 47.47%, with operating and profit margins of -507.8% and -160.63%.
Gross Margin 47.47% Operating Margin -507.8% Pretax Margin -517.76% Profit Margin -160.63% EBITDA Margin -480.83% EBIT Margin -507.8% FCF Margin -466.78%
Dividends & Yields FGEN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for FGEN is $43,
which is 249.3% higher than the current price. The consensus rating is "Buy".
Price Target $43 Price Target Difference 249.3% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 17, 2025. It was a
backward
split with a ratio of 1:25.
Last Split Date Jun 17, 2025 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -17.59 Piotroski F-Score 3
